Fremanezumab
Trump says pharma tariffs may touch 250% in 18 months; FDA okays Jazz Pharma’s rare brain tumor drug

Trump says pharma tariffs may touch 250% in 18 months; FDA okays Jazz Pharma’s rare brain tumor drug

The US Food and Drug Administration (FDA) has granted an accelerated approval to Jazz Pharmaceuticals’ Modeyso, a drug th...

Impressions : 1160

Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan

This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the presence of an additional ...

Impressions : 2769